A detailed history of South Street Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, South Street Advisors LLC holds 229,765 shares of HALO stock, worth $13.7 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
229,765
Previous 171,415 34.04%
Holding current value
$13.7 Million
Previous $9.81 Million 12.02%
% of portfolio
1.69%
Previous 1.49%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$42.57 - $61.09 $2.48 Million - $3.56 Million
58,350 Added 34.04%
229,765 $11 Million
Q3 2024

Nov 06, 2024

BUY
$51.3 - $64.42 $8.79 Million - $11 Million
171,415 New
171,415 $9.81 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.29B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track South Street Advisors LLC Portfolio

Follow South Street Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on South Street Advisors LLC with notifications on news.